Expert: Device makers should assess reimbursement early

01/27/2010 | Clinica (subscription required)

Medical-device makers should assess the potential reimbursement rates of products at the early stage of the development process, writes John Avellanet, Cerulean Associates' managing director. Evaluating the reimbursement implications early on could help companies to determine the profitability of a product before it reaches the market, Avellanet said.

View Full Article in:

Clinica (subscription required)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC